发布求助
文献互助 智能选刊 最新文献

Journal of Korean Neurosurgical Society最新文献

筛选
英文 中文
A Study on Prognostic Risk Factors of Cervical Spondylotic Myelopathy. 脊髓型颈椎病预后危险因素的研究。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-20 DOI: 10.3340/jkns.2025.0021
Zihan Zhou, Yunxin Su, Yuqi Shao, Jiayun Liu, Xincan Wu, Peng Gao, Tao Qin, Kaixiao Xue, Guoyong Yin, Jian Chen
{"title":"A Study on Prognostic Risk Factors of Cervical Spondylotic Myelopathy.","authors":"Zihan Zhou, Yunxin Su, Yuqi Shao, Jiayun Liu, Xincan Wu, Peng Gao, Tao Qin, Kaixiao Xue, Guoyong Yin, Jian Chen","doi":"10.3340/jkns.2025.0021","DOIUrl":"https://doi.org/10.3340/jkns.2025.0021","url":null,"abstract":"<p><strong>Objective: </strong>To identify the risk factors that influence the prognosis of patients with cervical spondylotic myelopathy (CSM).</p><p><strong>Methods: </strong>Clinical data were collected from 158 CSM patients treated between January 2023 and January 2024 at a tertiary medical center. The data were retrospectively analyzed, with a one-year follow-up. Based on the Japanese Orthopaedic Association score, patients were categorized into good and poor recovery groups. Clinical characteristics, laboratory indices, and imaging findings were compared between the groups, and risk factors affecting CSM prognosis were identified.</p><p><strong>Results: </strong>In a multivariable analysis, age, symptom duration, preoperative Japanese Orthopaedic Association (JOA) score, spinal cord compression ratio, Treg cell count, the number of surgical levels and diabetes history were identified as significant predictors of postoperative outcomes. Interestingly, Treg cell counts showed a novel positive correlation with improvement rates (P < 0.001), suggesting their potential role in spinal cord recovery after surgery.</p><p><strong>Conclusion: </strong>These findings underscore the prognostic relevance of clinical and immunological factors for predicting surgical outcomes in CSM. The observed association between peripheral Treg counts and recovery rates reveals new insights into the immunological mechanisms underlying CSM prognosis, suggesting potential targets for personalized treatment strategies.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Nomogram Model for Predicting the Prognosis of Patients with Brainstem Glioma : A Population-based Study. 预测脑干胶质瘤患者预后的临床Nomogram模型：一项基于人群的研究。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-20 DOI: 10.3340/jkns.2025.0037
Rui Zhang, Gaoyue Jiang, Yanming Ren, Yuekang Zhang, Xiaodong Niu
{"title":"Clinical Nomogram Model for Predicting the Prognosis of Patients with Brainstem Glioma : A Population-based Study.","authors":"Rui Zhang, Gaoyue Jiang, Yanming Ren, Yuekang Zhang, Xiaodong Niu","doi":"10.3340/jkns.2025.0037","DOIUrl":"https://doi.org/10.3340/jkns.2025.0037","url":null,"abstract":"<p><strong>Objective: </strong>The current understanding and clinical prediction of brainstem glioma (BSG) are still limited. This study aimed to conduct a large-scale population-based study to construct a clinical predictive model.</p><p><strong>Methods: </strong>Patients with BSG diagnosed histologically from 1973 to 2016 were identified using the SEER database. According to WHO grade, the whole population was divided into the LGBSG cohort and the HGBSG cohort. Univariate and multivariate cox regression analyses were employed to determine prognostic factors of OS. All independently prognostic variables were further used to construct nomograms to predict the 1- and 2-year overall survival probability. The precision and reliability of the nomogram were evaluated by C-index and calibration plots.</p><p><strong>Results: </strong>Cox regression analysis showed that four independent prognostic factors, were identified in the LGBSG cohort and two independent prognostic factors were identified in the HGBSG cohort. These independently prognostic factors and the main demographic data were further used to construct clinical nomograms for the LGBSG and HGBSG cohorts, respectively. The C-index for the internal validation was 0.89 (95%CI, 0.83-0.95) and 0.64 (95%CI, 0.60-0.68) in the LGBSG and HGBSG cohorts, respectively. The results of the calibration plots showed that the actual observation and prediction values obtained by the nomogram had good consistency in the LGBSG and HGBSG cohorts.</p><p><strong>Conclusion: </strong>This study identified several independent prognostic variables and further constructed the clinical nomogram model. The nomogram model can provide valuable clinical reference and risk assessments for clinicians to further manage these patients with BSG.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Constitutional Mismatch Repair Deficiency, the Most Aggressive Cancer Predisposition Syndrome : Clinical Presentation, Surveillance, and Management. 体质错配修复缺陷，最具侵略性的癌症易感性综合征：临床表现，监测和管理。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-04-29 DOI: 10.3340/jkns.2025.0024
Eungu Kang, Jin Kyung Suh, Sang-Dae Kim
{"title":"Constitutional Mismatch Repair Deficiency, the Most Aggressive Cancer Predisposition Syndrome : Clinical Presentation, Surveillance, and Management.","authors":"Eungu Kang, Jin Kyung Suh, Sang-Dae Kim","doi":"10.3340/jkns.2025.0024","DOIUrl":"https://doi.org/10.3340/jkns.2025.0024","url":null,"abstract":"<p><p>Constitutional mismatch repair deficiency (CMMRD) is a rare and highly aggressive cancer predisposition syndrome caused by biallelic germline mutations in mismatch repair genes. This condition is characterized by early-onset malignancies across multiple organ systems, including central nervous system tumors, hematological cancers, and gastrointestinal malignancies. CMMRD-associated tumors exhibit hypermutation and microsatellite instability, resulting in a high tumor mutation burden and rendering these malignancies responsive to immune checkpoint inhibitors (ICIs). ICIs targeting programmed cell death protein-1 and programmed cell death ligand 1 have demonstrated remarkable efficacy, particularly in hypermutated tumors, providing durable responses and improving survival outcomes. Advances in genetic and molecular diagnostics have enhanced the ability to identify CMMRD early, allowing for the implementation of comprehensive surveillance programs and improved management strategies. A multidisciplinary and individualized approach is essential for managing CMMRD patients. This review underscores the importance of early diagnosis, surveillance, and emerging therapeutic approaches to improve outcomes and quality of life for individuals and families affected by this devastating syndrome.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":"68 3","pages":"294-304"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhabdoid Tumor Predisposition Syndrome : A Comprehensive Review of Genetics, Clinical Manifestations, and Management. 横纹肌样肿瘤易感综合征：遗传学、临床表现和管理的综合综述。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-03-27 DOI: 10.3340/jkns.2025.0014
Taehoon Kim, Ji Hoon Phi
{"title":"Rhabdoid Tumor Predisposition Syndrome : A Comprehensive Review of Genetics, Clinical Manifestations, and Management.","authors":"Taehoon Kim, Ji Hoon Phi","doi":"10.3340/jkns.2025.0014","DOIUrl":"10.3340/jkns.2025.0014","url":null,"abstract":"<p><p>Rhabdoid tumor predisposition syndrome (RTPS) is a rare autosomal dominant disorder characterized by an increased risk of developing malignant rhabdoid tumors in early childhood. This syndrome is primarily caused by germline heterozygous loss-of-function pathogenic variants in the SMARCB1 gene (RTPS1) and rarely in the SMARCA4 gene (RTPS2). RTPS is characterized by the development of atypical teratoid rhabdoid tumors of the central nervous system, malignant rhabdoid tumors of the kidney, and/or extrarenal extracranial rhabdoid tumors. The syndrome demonstrates high penetrance, with most tumors developing before age 3 years, and carries a poor prognosis despite intensive multimodal therapy. Early diagnosis through genetic testing, implementation of surveillance protocols, and aggressive treatment approaches are crucial for improving outcomes. This review comprehensively examines the genetic basis, clinical manifestations, surveillance strategies, and current management approaches for RTPS, with particular emphasis on emerging therapeutic options and the importance of multidisciplinary care.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"311-320"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143719773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Li-Fraumeni Syndrome : Current Strategies and Future Perspectives. Li-Fraumeni综合征：当前策略和未来展望。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-04-29 DOI: 10.3340/jkns.2025.0050
Ji Won Lee
{"title":"Li-Fraumeni Syndrome : Current Strategies and Future Perspectives.","authors":"Ji Won Lee","doi":"10.3340/jkns.2025.0050","DOIUrl":"https://doi.org/10.3340/jkns.2025.0050","url":null,"abstract":"<p><p>Li-Fraumeni syndrome (LFS) is a rare inherited cancer predisposition syndrome caused by germline mutations in the TP53 tumor suppressor gene. It predisposes affected individuals to a wide spectrum of early-onset malignancies, including sarcomas, breast cancer, brain tumors, and adrenocortical carcinoma. Advances in genetic testing and risk management strategies have enhanced the identification and clinical management of LFS patients. Comprehensive surveillance has demonstrated increased survival rates through proactive screening. Beyond surveillance, research is exploring novel approaches such as liquid biopsy for early cancer detection and chemoprevention strategies, including metformin trials, to mitigate cancer risk. This review discusses the molecular basis, clinical spectrum, surveillance strategies, and emerging research in LFS.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":"68 3","pages":"305-310"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144015433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment. 丛状神经纤维瘤的治疗：外科和内科治疗的最新进展。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-04-30 DOI: 10.3340/jkns.2025.0041
Jun Kyu Hwang, Se Hoon Kim, Dong-Seok Kim
{"title":"Treatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment.","authors":"Jun Kyu Hwang, Se Hoon Kim, Dong-Seok Kim","doi":"10.3340/jkns.2025.0041","DOIUrl":"https://doi.org/10.3340/jkns.2025.0041","url":null,"abstract":"<p><p>Plexiform neurofibromas (PNFs), a critical clinical feature of neurofibromatosis type 1, mainly involve several peripheral nerve branches and extend widely, including the skin and bones and the internal organs. Determining the appropriate treatment is difficult. Additionally, they possess the potential to develop into malignant peripheral nerve sheath tumors (MPNSTs), which are linked to an extremely poor prognosis. Active treatment is critical in patients with symptoms or progressive tumor growth, especially in pediatric cases. Surgery remains the standard treatment for managing PNFs and MPNSTs; however, it has often demonstrated insufficient results because of its wide distribution and the frequent involvement of major organs. Selumetinib, a recently approved mitogen-activated protein kinase kinase inhibitor, is gaining traction in treating inoperable PNFs in children.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":"68 3","pages":"252-260"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144007014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Perspectives into the Combined Pterional and Interhemispheric Approach during Ruptured Anterior Communicating Artery Aneurysm Surgery in the Endovascular Treatment Era. 在血管内治疗时代前交通动脉瘤破裂手术中翼点与半球联合入路的新观点。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-02-06 DOI: 10.3340/jkns.2025.0020
Dong-Seong Shin, Ho Jun Yi, Seung-Jae Lee, Bum-Tae Kim
{"title":"New Perspectives into the Combined Pterional and Interhemispheric Approach during Ruptured Anterior Communicating Artery Aneurysm Surgery in the Endovascular Treatment Era.","authors":"Dong-Seong Shin, Ho Jun Yi, Seung-Jae Lee, Bum-Tae Kim","doi":"10.3340/jkns.2025.0020","DOIUrl":"10.3340/jkns.2025.0020","url":null,"abstract":"","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"369-372"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Genetic Overview of Neurofibromatosis Type 2 (NF2). 2型神经纤维瘤病（NF2）的临床和遗传学综述。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-03-14 DOI: 10.3340/jkns.2025.0048
Tae-Kyun Kim, Young-Soo Park, Ichiro Nakagawa
{"title":"Clinical and Genetic Overview of Neurofibromatosis Type 2 (NF2).","authors":"Tae-Kyun Kim, Young-Soo Park, Ichiro Nakagawa","doi":"10.3340/jkns.2025.0048","DOIUrl":"10.3340/jkns.2025.0048","url":null,"abstract":"<p><p>Neurofibromatosis type 2 (NF2) is an autosomal dominant disease characterized by bilateral vestibular schwannomas and other central nervous tumors such as meningiomas and spinal ependymomas. Symptoms vary according to the age at diagnosis and the location of these tumors. The diagnostic criteria of NF2 have been regularly revised and recently updated in 2022 with a new nomenclature \"NF2-related schwannomatosis\" to differentiate NF2 from other schwannoma predisposing disorders, such as SMARCB1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1)-, LZTR1 (leucine zipper-like transcription regulator 1)-, and 22q-related schwannomatosis. Addition to the clinical features, genetic testing for pathogenic variants in these genes became an important essence to support diagnosis of NF2 and other schwannomatosis, including mosaic conditions.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"272-277"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Von Hippel-Lindau Disease : A Comprehensive Review of Diagnosis, Genetics, Clinical Challenges, and Surveillance. 希佩尔-林道病：诊断、遗传学、临床挑战和监测的综合综述。
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-03-20 DOI: 10.3340/jkns.2025.0018
Na Young Jung, Jun Bum Park
{"title":"Von Hippel-Lindau Disease : A Comprehensive Review of Diagnosis, Genetics, Clinical Challenges, and Surveillance.","authors":"Na Young Jung, Jun Bum Park","doi":"10.3340/jkns.2025.0018","DOIUrl":"10.3340/jkns.2025.0018","url":null,"abstract":"<p><p>von Hippel-Lindau (VHL) disease is a genetic condition predisposing individuals to the development of benign and malignant tumors across various organs. This review explores the intricate genetic underpinnings of VHL disease, its clinical manifestations, and the associated malignancy risks. The latest diagnostic criteria, surveillance guidelines, and advancements in therapeutic strategies, including the Food and Drug Administration-approved hypoxia-inducible factor-2α inhibitor, belzutifan, are focused on. Through a multidisciplinary approach, tailored surveillance programs aim to improve patient outcomes while balancing intervention risks. Emerging technologies such as wholebody magnetic resonance imaging and liquid biopsies hold promises for enhancing non-invasive surveillance. This review underscores the significance of ongoing research and interdisciplinary care in managing this complex syndrome.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"338-349"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management Strategies of Neurofibromatosis Type 2 in Pediatric Patients : Challenges and Emerging Therapies. 小儿2型神经纤维瘤病的治疗策略：挑战和新兴疗法
IF 1.4 4区 医学
Journal of Korean Neurosurgical Society Pub Date : 2025-05-01 Epub Date: 2025-02-24 DOI: 10.3340/jkns.2024.0237
Jong Seok Lee
{"title":"Management Strategies of Neurofibromatosis Type 2 in Pediatric Patients : Challenges and Emerging Therapies.","authors":"Jong Seok Lee","doi":"10.3340/jkns.2024.0237","DOIUrl":"10.3340/jkns.2024.0237","url":null,"abstract":"<p><p>Neurofibromatosis type 2 (NF2) is a rare genetic disorder caused by mutations in the NF2 tumor suppressor gene, characterized by bilateral vestibular schwannomas and other central and peripheral nervous system tumors. Pediatric patients often present with more aggressive disease, greater tumor burdens, and increased morbidity compared to adults. Management requires a multidisciplinary approach that balances tumor control with functional preservation. While surgery and radiosurgery remain key treatment options, they carry risks such as hearing loss and malignant transformation of existing tumors. Bevacizumab and emerging therapies like gene therapy show promising therapeutic effects but are limited by variability in efficacy. Comprehensive care, including psychosocial support, is essential to improve clinical outcomes and quality of life for children with NF2.</p>","PeriodicalId":16283,"journal":{"name":"Journal of Korean Neurosurgical Society","volume":" ","pages":"278-285"},"PeriodicalIF":1.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143483418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信